Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026)
Korro Bio's Other Accumulated Expenses came in at $105,000 for Q2 2026, down 19.2% from $130,000 a year earlier and down 40.0% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Other Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, Korro Bio's Other Accumulated Expenses was $70,000, down 74.7% from FY2024.
- Other Accumulated Expenses carries a three-year compound annual growth rate of -30.3% (FY2022 to FY2025).
- Going back by year, Other Accumulated Expenses was $277,000 in FY2024 (-38.0%), $447,000 in FY2023 (+115.9%) and $207,000 in FY2022.
- The five-year range for quarterly Other Accumulated Expenses is $70,000 (Q4 2025) to $493,000 (Q1 2025).
- Year-over-year, Other Accumulated Expenses has declined for five consecutive quarters, with an average decline of 4.6% over the last seven quarters.
- The fastest year-over-year change in Other Accumulated Expenses over five years came in Q1 2025 (growth of 252.1%), and the weakest in Q4 2025 (a decline of 74.7%).
- Business Quant data shows KRRO's Other Accumulated Expenses at $175,000 (Q1 2026), $70,000 (Q4 2025) and $111,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Korro Bio | 281.05 Mn | -128.11 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 118,000.00 |
| Jun 30, 2026 | 105,000.00 |
| Mar 31, 2026 | 175,000.00 |
| Dec 31, 2025 | 70,000.00 |
| Sep 30, 2025 | 111,000.00 |
| Jun 30, 2025 | 130,000.00 |
| Mar 31, 2025 | 493,000.00 |
| Dec 31, 2024 | 277,000.00 |
| Sep 30, 2024 | 186,000.00 |
| Jun 30, 2024 | 247,000.00 |
| Mar 31, 2024 | 140,000.00 |
| Dec 31, 2023 | 447,000.00 |
| Dec 31, 2022 | 207,000.00 |
| Sep 30, 2022 | 296,000.00 |
| Dec 31, 2019 | 170,000.00 |
| Sep 30, 2019 | 16.00 Mn |
| Dec 31, 2018 | 161,000.00 |
API Access
Korro Bio Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();